HedgeChatter

  • Home /
  • Tag Archives

STML

Stemline Therapeutics, Inc. Announces Exercise of Over-Allotment Option

[at noodls] – NEW YORK, Jan. 29, 2013 (GLOBE NEWSWIRE) — Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing oncology therapeutics that target both cancer stem cells (CSCs) … moreView todays social media effects on STMLView the latest stocks trending across Twitter. Click to view dashboardSee who Stemline is hiring next, click here to view […]

February 1, 2013 Bystocknews , Comments Off on Stemline Therapeutics, Inc. Announces Exercise of Over-Allotment Option read more

Stemline Therapeutics, Inc. Announces Closing of Initial Public Offering

[at noodls] – NEW YORK, Jan. 31, 2013 (GLOBE NEWSWIRE) — Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing oncology therapeutics that target both cancer stem cells (CSCs) … moreView todays social media effects on STMLView the latest stocks trending across Twitter. Click to view dashboardSee who Stemline is hiring next, click here to view […]

February 1, 2013 Bystocknews , Comments Off on Stemline Therapeutics, Inc. Announces Closing of Initial Public Offering read more